Extracellular BCL2 proteins are danger-associated molecular patterns that reduce tissue damage in murine models of ischemia-reperfusion injury

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Iwata, Akiko ^a   Morgan Stevenson, Vicki ^a   Schwartz, Barbara ^b   Liu, Li ^b   Tupper, Joan ^b   Zhu, Xiaodong ^b   Harlan, John ^b   Winn, Robert ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCL2 RELATED PROTEIN A1; MYELOID DIFFERENTIATION FACTOR 88; PEPTIDE; PROTEIN BCL 2; TOLL LIKE RECEPTOR 2; BCL2 PROTEIN, MOUSE; BCL2-RELATED PROTEIN A1; ONCOPROTEIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DANGER ASSOCIATED MOLECULAR PATTERN; DISEASE SEVERITY; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HINDLIMB; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SKELETAL MUSCLE; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; GENETICS; HUMAN; MOLECULAR GENETICS; MOUSE MUTANT; PATHOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TOURNIQUET; VASCULARIZATION;

MURINAE; MUS;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; HINDLIMB; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; MYELOID DIFFERENTIATION FACTOR 88; MYOCARDIAL ISCHEMIA; PEPTIDES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOURNIQUETS;

EID: 77949418652     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009103     Document Type: Article

References (59)

1. Matzinger P (2002) The danger model: a renewed sense of self. Science 296: 301-305.
2. Bianchi ME (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81: 1-5.
3. Kono H, Rock KL (2008) How dying cells alert the immune system to danger. Nat Rev Immunol 8: 279-289.
4. Reed JC (2008) Bcl-2-family proteins and hematologic malignancies: history and future prospects. Blood 111: 3322-3330.
5. Iwata A, Stevenson VM, Minard A, Tasch M, Tupper J, et al. (2003) Over-expression of Bcl-2 provides protection in septic mice by a trans effect. J Immunol 171: 3136-3141.
6. Zhang H, Cowan-Jacob SW, Simonen M, Greenhalf W, Heim J, et al. (2000) Structural basis of BFL-1 for its interaction with BAX and its anti-apoptotic action in mammalian and yeast cells. J Biol Chem 275: 11092-11099.
7. Iwata A, Harlan JM, Vedder NB, Winn RK (2002) The caspase inhibitor z-VAD is more effective than CD18 adhesion blockade in reducing muscle ischemia-reperfusion injury: implication for clinical trials. Blood 100: 2077-2080.
8. Kyriakides C, Austen WG Jr, Wang Y, Favuzza J, Moore FD Jr, et al. (2000) Neutrophil mediated remote organ injury after lower torso ischemia and reperfusion is selectin and complement dependent. J Trauma 48: 32-38.
9. Ferrera R, Larese A, Berthod F, Guidollet J, Rodriguez C, et al. (1993) Quantitative reduction of MTT by hearts biopsies in vitro is an index of viability. J Mol Cell Cardiol 25: 1091-1099.
10. Carter WO, Bull C, Bortolon E, Yang L, Jesmok GJ, et al. (1998) A murine skeletal muscle ischemia-reperfusion injury model: differential pathology in BALB/c and DBA/2N mice. J Appl Physiol 85: 1676-1683.
11. Lin EY, Orlofsky A, Berger MS, Prystowsky MB (1993) Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J Immunol 151: 1979-1988.
12. Choi SS, Park IC, Yun JW, Sung YC, Hong SI, et al. (1995) A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 11: 1693-1698.
13. Karsan A, Yee E, Kaushansky K, Harlan JM (1996) Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. Blood 87: 3089-3096.
14. Miyake K (2007) Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin Immunol 19: 3-10.
15. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
16. Santos-Sierra S, Deshmukh SD, Kalnitski J, Kuenzi P, Wymann MP, et al. (2009) Mal connects TLR2 to PI3Kinase activation and phagocyte polarization. Embo J 28: 2018-2027.
17. Reed JC, Doctor KS, Godzik A (2004) The domains of apoptosis: a genomics perspective. Sci STKE 2004: re9.
18. Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, et al. (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381: 335-341.
19. Petros AM, Medek A, Nettesheim DG, Kim DH, Yoon HS, et al. (2001) Solution structure of the antiapoptotic protein bcl-2. Proc Natl Acad Sci U S A 98: 3012-3017.
20. Huang DC, Adams JM, Cory S (1998) The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4. Embo J 17: 1029-1039.
21. Cory S, Huang DC, Adams JM (2003) The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22: 8590-8607.
22. Shimizu S, Konishi A, Kodama T, Tsujimoto Y (2000) BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc Natl Acad SciUS A 97: 3100-3105.
23. Cantara S, Donnini S, Giachetti A, Thorpe PE, Ziche M (2004) Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress. J Vasc Res 41: 202-207.
24. Klein D, Ribeiro MM, Mendoza V, Jayaraman S, Kenyon NS, et al. (2004) Delivery of Bcl-XL or its BH4 domain by protein transduction inhibits apoptosis in human islets. Biochem Biophys Res Commun 323: 473-478.
25. Hotchkiss RS, McConnell KW, Bullok K, Davis CG, Chang KC, et al. (2006) TAT-BH4 and TAT-Bcl-xL peptides protect against sepsis-induced lymphocyte apoptosis in vivo. J Immunol 176: 5471-5477.
26. Ono M, Sawa Y, Ryugo M, Alechine AN, Shimizu S, et al. (2005) BH4 peptide derivative from Bcl-xL attenuates ischemia/reperfusion injury thorough anti-apoptotic mechanism in rat hearts. Eur J Cardiothorac Surg 27: 117-121.
27. Sugioka R, Shimizu S, Funatsu T, Tamagawa H, Sawa Y, et al. (2003) BH4-domain peptide from Bcl-xL exerts anti-apoptotic activity in vivo. Oncogene 22: 8432-8440.
28. Li M, Carpio DF, Zheng Y, Bruzzo P, Singh V, et al. (2001) An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol 166: 7128-7135.
29. Kim HS, Han MS, Chung KW, Kim S, Kim E, et al. (2007) Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes. Immunity 27: 321-333.
30. Arumugam TV, Okun E, Tang SC, Thundyil J, Taylor SM, et al. (2009) Toll-like receptors in ischemia-reperfusion injury. Shock 32: 4-16.
31. Hua F, Ma J, Ha T, Kelley J, Williams DL, et al. (2008) Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury. J Neuroimmunol 199: 75-82.
32. Aprahamian CJ, Lorenz RG, Harmon CM, Dimmit RA (2008) Toll-like receptor 2 is protective of ischemia-reperfusion-mediated small-bowel injury in a murine model. Pediatr Crit Care Med 9: 105-109.
33. Hua F, Ma J, Ha T, Kelley JL, Kao RL, et al. (2009) Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in mice. Brain Res 1262: 100-108.
34. Chen Z, Chua CC, Ho YS, Hamdy RC, Chua BH (2001) Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am J Physiol Heart Circ Physiol 280: H2313-2320.
35. Brocheriou V, Hagege AA, Oubenaissa A, Lambert M, Mallet VO, et al. (2000) Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J Gene Med 2: 326-333.
36. Coopersmith CM, O'Donnell D, Gordon JI (1999) Bcl-2 inhibits ischemiareperfusion-induced apoptosis in the intestinal epithelium of transgenic mice. Am J Physiol 276: G677-686.
37. Cao YJ, Shibata T, Rainov NG (2002) Liposome-mediated transfer of the bcl-2 gene results in neuroprotection after in vivo transient focal cerebral ischemia in an animal model. Gene Ther 9: 415-419.
38. Bilbao G, Contreras JL, Eckhoff DE, Mikheeva G, Krasnykh V, et al. (1999) Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic Bcl-2 gene. Ann Surg 230: 185-193.
39. Selzner M, Rudiger HA, Selzner N, Thomas DW, Sindram D, et al. (2002) Transgenic mice overexpressing human Bcl-2 are resistant to hepatic ischemia and reperfusion. J Hepatol 36: 218-225.
40. Oshiro T, Shiraishi M, Muto Y (2002) Adenovirus mediated gene transfer of antiapoptotic protein in hepatic ischemia-reperfusion injury: the paradoxical effect of Bcl-2 expression in the reperfused liver. J Surg Res 103: 30-36.
41. Klune JR, Billiar TR, Tsung A (2008) HMGB1 preconditioning: therapeutic application for a danger signal? J Leukoc Biol 83: 558-563.
42. Barbalat R, Lau L, Locksley RM, Barton GM (2009) Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat Immunol 10: 1200-1207.
43. Rouhiainen A, Tumova S, Valmu L, Kalkkinen N, Rauvala H (2007) Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). J Leukoc Biol 81: 49-58.
44. Sha Y, Zmijewski J, Xu Z, Abraham E (2008) HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol 180: 2531-2537.
45. Hreggvidsdottir HS, Ostberg T, Wahamaa H, Schierbeck H, Aveberger AC, et al. (2009) The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J Leukoc Biol 86: 655-662.
46. Izuishi K, Tsung A, Jeyabalan G, Critchlow ND, Li J, et al. (2006) Cutting edge: high-mobility group box 1 preconditioning protects against liver ischemiareperfusion injury. J Immunol 176: 7154-7158.
47. Brown GD (2006) Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 6: 33-43.
48. Soong G, Reddy B, Sokol S, Adamo R, Prince A (2004) TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. J Clin Invest 113: 1482-1489.
49. Hajishengallis G, Wang M, Liang S, Triantafilou M, Triantafilou K (2008) Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function. Proc Natl Acad Sci U S A 105: 13532-13537.
50. Li C, Ha T, Kelley J, Gao X, Qiu Y, et al. (2004) Modulating Toll-like receptor mediated signaling by (1->3)-beta-D-glucan rapidly induces cardioprotection. Cardiovasc Res 61: 538-547.
51. Sakai T, Inoue A, Koh CS, Osame M (1999) Serum levels of apoptosis-related molecules in patients with multiple sclerosis and human T-lymphotropic virus Type I-associated myelopathy. J Interferon Cytokine Res 19: 999-1004.
52. Fathi NA, Hussein MR, Hassan HI, Mosad E, Galal H, et al. (2006) Glomerular expression and elevated serum Bcl-2 and Fas proteins in lupus nephritis: preliminary findings. Clin Exp Immunol 146: 339-343.
53. Osman HG, Gabr OM, Lotfy S, Gabr S (2007) Serum levels of bcl-2 and cellular oxidative stress in patients with viral hepatitis. Indian J Med Microbiol 25: 323-329.
54. Camlica H, Duranyildiz D, Tas F, Yasasever V (2008) Statistical interpretation of CA125 and Bcl-2 in serum of patients with late stage ovarian cancer. Am J Clin Oncol 31: 585-588.
55. Protopsaltis J, Kokkoris S, Nikolopoulos G, Spyropoulou P, Katsaros T, et al. (2007) Correlation between increased serum sFas levels and microalbuminuria in type 1 diabetic patients. Med Princ Pract 16: 222-225.
56. Uzan M, Erman H, Tanriverdi T, Sanus GZ, Kafadar A, et al. (2006) Evaluation of apoptosis in cerebrospinal fluid of patients with severe head injury. Acta Neurochir (Wien) 148: 1157-1164; discussion.
57. Clark RS, Kochanek PM, Adelson PD, Bell MJ, Carcillo JA, et al. (2000) Increases in bcl-2 protein in cerebrospinal fluid and evidence for programmed cell death in infants and children after severe traumatic brain injury. J Pediatr 137: 197-204.
58. Hirotani M, Zhang Y, Fujita N, Naito M, Tsuruo T (1999) NH2-terminal BH4 domain of Bcl-2 is functional for heterodimerization with Bax and inhibition of apoptosis. J Biol Chem 274: 20415-20420.
59. Hill JA, Karimi M, Kutschke W, Davisson RL, Zimmerman K, et al. (2000) Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation 101: 2863-2869.